EUVIMEDEUVIMED entdecken
Open Access

Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

Eliza C Miller iD, Anni Kauko iD, Sarah E Tom iD, Hannele Laivuori iD, Teemu Niiranen iD, Natalie A Bello iD, FinnGen Investigators

Stroke · 2023-07 · 54 (7) · 1798-1805

DOI: 10.1161/strokeaha.123.043052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2023-07. Verfasst von Eliza C Miller und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Columbia University, New York (E.C.M., S.E.T.). Hauptthemen laut MEDLINE: Premature Birth, Pre-Eclampsia, Hypertension, Pregnancy-Induced, Stroke. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Adverse pregnancy outcomes (APO) contribute to higher risk of maternal cerebrovascular disease, but longitudinal data that include APO and stroke timing are lacking. We hypothesized that APO are associated with younger age at first stroke, with a stronger relationship in those with >1 pregnancy with APO. METHODS: We analyzed longitudinal Finnish nationwide health registry data from the FinnGen Study. We included women who gave birth after 1969 when the hospital discharge registry was established. We defined APO as a pregnancy affected by gestational hypertension, preeclampsia, eclampsia, preterm birth, small for gestational age infant, or placental abruption. We defined stroke as first hospital admission for ischemic stroke or nontraumatic intracerebral or subarachnoid hemorrhage, excluding stroke during pregnancy or within 1 year postpartum. We used Kaplan-Meier survival curves and multivariable-adjusted Cox and generalized linear models to assess the relationship between APO and future stroke. RESULTS: We included 144 306 women with a total of 316 789 births in the analysis sample, of whom 17.9% had at least 1 pregnancy with an APO and 2.9% experienced an APO in ≥2 pregnancies. Women with APO had more comorbidities including obesity, hypertension, heart disease, and migraine. Median age at first stroke was 58.3 years in those with no APO, 54.8 years in those with 1 APO, and 51.6 years in those with recurrent APO. In models adjusted for sociodemographic characteristics and stroke risk factors, risk of stroke was greater in women with 1 APO (adjusted hazard ratio, 1.3 [95% CI, 1.2–1.4]) and recurrent APO (adjusted hazard ratio, 1.4 [95% CI, 1.2–1.7]) compared with those with no APO. Women with recurrent APO had more than twice the stroke risk before age 45 (adjusted odds ratio, 2.1 [95% CI, 1.5–3.1]) compared with those without APO. CONCLUSIONS: Women who experience APO have earlier onset of cerebrovascular disease, with the earliest onset in those with more than 1 affected pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Premature BirthPre-EclampsiaHypertension, Pregnancy-InducedStrokePregnancyFemaleInfant, NewbornHumansMiddle AgedMalePlacentaPregnancy OutcomeRisk Factors

Stichwörter der Autor:innen

cerebrovascular disordershypertension, pregnancy-inducedpregnancystroke

Autor:innen und Institutionen

  • Department of Neurology, Columbia University, New York (E.C.M., S.E.T.).
  • Department of Internal Medicine, University of Turku, Finland (A.K., T.N.).
  • Department of Epidemiology, Columbia University, New York (S.E.T.).
  • Department of Obstetrics and Gynecology, Tampere University Hospital, Finland (H.L.).
  • Center for Child, Adolescent, and Maternal Health Research, Tampere University, Finland (H.L.).
  • Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Tampere University (H.L.).

ORCID-Profile: Eliza C Miller, Anni Kauko, Sarah E Tom, Hannele Laivuori, Teemu Niiranen, Natalie A Bello

Förderung

  • NINDS NIH HHS
  • NHLBI NIH HHS
  • NIA NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Miller, E. C., Kauko, A., Tom, S. E., Laivuori, H., Niiranen, T., Bello, N. A., & FinnGen Investigators (2023). Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study. Stroke, 54(7), 1798-1805. https://doi.org/10.1161/strokeaha.123.043052

Vancouver

Miller EC, Kauko A, Tom SE, Laivuori H, Niiranen T, Bello NA, et al. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study. Stroke. 2023;54(7):1798-1805. doi:10.1161/strokeaha.123.043052

BibTeX
@article{Miller2023,
  author = {Miller, Eliza C and Kauko, Anni and Tom, Sarah E and Laivuori, Hannele and Niiranen, Teemu and Bello, Natalie A and FinnGen Investigators, FinnGen Investigators},
  title = {Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study},
  journal = {Stroke},
  year = {2023},
  volume = {54},
  number = {7},
  pages = {1798--1805},
  doi = {10.1161/strokeaha.123.043052}
}
Kostenlos starten →